1 Natural Killer (NK) Cell Therapeutics Market Overview
1.1 Natural Killer (NK) Cell Therapeutics Product Overview
1.2 Natural Killer (NK) Cell Therapeutics Market Segment by Type
1.2.1 Mogamulizumab
1.2.2 Lorvotuzumab Mertansine
1.2.3 Others
1.3 Global Natural Killer (NK) Cell Therapeutics Market Size by Type
1.3.1 Global Natural Killer (NK) Cell Therapeutics Sales and Growth by Type
1.3.2 Global Natural Killer (NK) Cell Therapeutics Sales and Market Share by Type (2015-2020)
1.3.3 Global Natural Killer (NK) Cell Therapeutics Revenue and Market Share by Type (2015-2020)
1.3.4 Global Natural Killer (NK) Cell Therapeutics Price by Type (2015-2020)
2 Global Natural Killer (NK) Cell Therapeutics Market Competition by Company
2.1 Global Natural Killer (NK) Cell Therapeutics Sales and Market Share by Company (2015-2020)
2.2 Global Natural Killer (NK) Cell Therapeutics Revenue and Share by Company (2015-2020)
2.3 Global Natural Killer (NK) Cell Therapeutics Price by Company (2015-2020)
2.4 Global Top Players Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution, Sales Area, Product Types
2.5 Natural Killer (NK) Cell Therapeutics Market Competitive Situation and Trends
2.5.1 Natural Killer (NK) Cell Therapeutics Market Concentration Rate
2.5.2 Global Natural Killer (NK) Cell Therapeutics Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Natural Killer (NK) Cell Therapeutics Company Profiles and Sales Data
3.1 Chipscreen Biosciences (China)
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Natural Killer (NK) Cell Therapeutics Product Category, Application and Specification
3.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin(2015-2020)
3.1.4 Main Business Overview
3.2 Affimed NV (Netherlands)
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Natural Killer (NK) Cell Therapeutics Product Category, Application and Specification
3.2.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin(2015-2020)
3.2.4 Main Business Overview
3.3 Altor BioScience Corporation (USA)
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Natural Killer (NK) Cell Therapeutics Product Category, Application and Specification
3.3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin(2015-2020)
3.3.4 Main Business Overview
3.4 Innate Pharma SA (France)
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Natural Killer (NK) Cell Therapeutics Product Category, Application and Specification
3.4.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin(2015-2020)
3.4.4 Main Business Overview
3.5 Takeda Pharmaceutical (Japan)
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Natural Killer (NK) Cell Therapeutics Product Category, Application and Specification
3.5.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin(2015-2020)
3.5.4 Main Business Overview
3.6 Sorrento Therapeutics Inc. (USA)
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Natural Killer (NK) Cell Therapeutics Product Category, Application and Specification
3.6.3 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin(2015-2020)
3.6.4 Main Business Overview
3.7 NantKwest Inc. (USA)
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Natural Killer (NK) Cell Therapeutics Product Category, Application and Specification
3.7.3 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin(2015-2020)
3.7.4 Main Business Overview
3.8 Bristol-Myers Squibb (USA)
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Natural Killer (NK) Cell Therapeutics Product Category, Application and Specification
3.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin(2015-2020)
3.8.4 Main Business Overview
3.9 NKT Therapeutics (USA)
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Natural Killer (NK) Cell Therapeutics Product Category, Application and Specification
3.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin(2015-2020)
3.9.4 Main Business Overview
4 Natural Killer (NK) Cell Therapeutics Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Natural Killer (NK) Cell Therapeutics Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Natural Killer (NK) Cell Therapeutics Sales and Revenue by Regions
4.2.1 Global Natural Killer (NK) Cell Therapeutics Sales and Market Share by Regions (2015-2020)
4.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2.3 Global Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2015-2020)
4.3 North America Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Natural Killer (NK) Cell Therapeutics Application/End Users
5.1 Natural Killer (NK) Cell Therapeutics Segment by Application
5.1.1 Cancer
5.1.2 Cardiovascular Diseases
5.1.3 Others
5.2 Global Natural Killer (NK) Cell Therapeutics Product Segment by Application
5.2.1 Global Natural Killer (NK) Cell Therapeutics Sales by Application
5.2.2 Global Natural Killer (NK) Cell Therapeutics Sales and Market Share by Application (2015-2020)
6 Global Natural Killer (NK) Cell Therapeutics Market Forecast
6.1 Global Natural Killer (NK) Cell Therapeutics Sales, Revenue Forecast (2021-2028)
6.1.1 Global Natural Killer (NK) Cell Therapeutics Sales and Growth Rate Forecast (2021-2028)
6.1.1 Global Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate Forecast (2021-2028)
6.2 Global Natural Killer (NK) Cell Therapeutics Forecast by Regions
6.2.1 North America Natural Killer (NK) Cell Therapeutics Sales and Revenue Forecast (2021-2028)
6.2.2 Europe Natural Killer (NK) Cell Therapeutics Sales and Revenue Forecast (2021-2028)
6.2.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Sales and Revenue Forecast (2021-2028)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Natural Killer (NK) Cell Therapeutics Sales and Revenue Forecast (2021-2028)
6.2.5 Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales and Revenue Forecast (2021-2028)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Natural Killer (NK) Cell Therapeutics Forecast by Type
6.3.1 Global Natural Killer (NK) Cell Therapeutics Sales and Revenue Forecast by Type (2021-2028)
6.3.2 Mogamulizumab Gowth Forecast
6.3.3 Lorvotuzumab Mertansine Gowth Forecast
6.4 Natural Killer (NK) Cell Therapeutics Forecast by Application
6.4.1 Global Natural Killer (NK) Cell Therapeutics Sales Forecast by Application (2021-2028)
6.4.2 Global Natural Killer (NK) Cell Therapeutics Forecast in Cancer
6.4.3 Global Natural Killer (NK) Cell Therapeutics Forecast in Cardiovascular Diseases
7 Natural Killer (NK) Cell Therapeutics Upstream Raw Materials
7.1 Natural Killer (NK) Cell Therapeutics Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Natural Killer (NK) Cell Therapeutics Industrial Chain Analysis
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer